The 13 most recent market catalysts affecting $MCK, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 25, 2026
Corporate Catalyst
Bullish
Impact 90
McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization
McKesson's acquisition of Precision Medicine Group for $2.25 billion is a major strategic move to bolster its clinical research and commercialization services. This deal allows McK…
Aug 25, 2026
Corporate Catalyst
Neutral
Impact 75
McKesson To Acquire Precision Medicine Group For ~$2.25
This acquisition is a significant corporate catalyst for McKesson, signaling a strategic focus on expanding its high-growth oncology and specialty care segments. The deal is likely…
Aug 19, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Maintains Overweight on McKesson, Raises Price Target to $1000
Barclays analyst Glen Santangelo maintained an 'Overweight' rating on McKesson (MCK) and raised the price target from $925 to $1000. This action signals a positive outlook from a p…
Aug 19, 2026
Corporate Catalyst
Neutral
Impact 55
RBC Capital Initiates Coverage On McKesson with Sector Perform Rating, Announces Price Target of $845
RBC Capital's initiation of coverage on McKesson (MCK) with a 'Sector Perform' rating and an $845 price target is a routine event in the life of a publicly traded company. While no…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933
Wells Fargo analyst Stephen Baxter maintained an 'Equal-Weight' rating on McKesson (MCK) but significantly raised the price target from $812 to $933. This action signals a more opt…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Buy on McKesson, Raises Price Target to $1006
TD Cowen analyst Charles Rhyee maintained a 'Buy' rating on McKesson and raised the price target from $989 to $1006. This action signals continued bullish sentiment from a prominen…
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Buy on McKesson, Raises Price Target to $1080
UBS analyst Kevin Caliendo maintained a 'Buy' rating on McKesson (MCK) and raised the price target from $1050 to $1080. This action signals continued bullish sentiment from a major…
Aug 6, 2026
Corporate Catalyst
Bearish
Impact 75
McKesson shares are trading lower despite reporting better-than-expected Q2 financial results and raising FY26 adjusted EPS guidance with its midpoint above estimates. The company's FY26 sales guidance midpoint is slightly above estimates, and management noted lower branded pharmaceutical pricing on its conference call.
McKesson's stock decline despite positive financial results highlights investor sensitivity to future revenue and margin pressures, specifically from 'lower branded pharmaceutical …
Aug 6, 2026
Corporate Catalyst
Bullish
Impact 55
Evercore ISI Group Maintains Outperform on McKesson, Raises Price Target to $1000
Evercore ISI Group analyst Elizabeth Anderson maintained an 'Outperform' rating on McKesson (MCK) and raised the price target from $860 to $1000. This action signals a strong vote …
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 85
McKesson shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY27 adjusted EPS guidance.
McKesson's positive earnings surprise and raised guidance are a strong bullish signal for the company, indicating effective management and a healthy demand environment for its serv…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 90
McKesson Q1 Adj. EPS $9.93 Beats $9.54 Estimate, Sales $105.380B Beat $103.738B Estimate
McKesson announced Q1 adjusted EPS of $9.93, significantly beating the $9.54 consensus estimate, and sales of $105.38 billion, also surpassing the $103.738 billion estimate. This s…
Jul 24, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on McKesson, Raises Price Target to $1000
Citigroup analyst Daniel Grosslight has maintained a 'Buy' rating on McKesson and raised the price target from $945 to $1000. This action signals increased analyst confidence in Mc…
Jul 22, 2026
Corporate Catalyst
Bullish
Impact 55
McKesson Raises Quarterly Dividend From $0.82 To $0.94 Per Share
McKesson's Board of Directors declared a 15% increase in its quarterly dividend, raising it from $0.82 to $0.94 per share. This action demonstrates the company's strong financial h…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.